血管外科指南

订阅

MedSci主页 / 所有栏目 / 血管外科指南

2022 AVF/AVLS/SVM专家共识：淋巴水肿的诊断和治疗

2022-03-08 美国静脉联盟 Phlebology

淋巴水肿

中文标题：

2022 AVF/AVLS/SVM专家共识：淋巴水肿的诊断和治疗

英文标题：

The American venous forum, American vein and lymphatic society and the society for vascular medicine expert opinion consensus on lymphedema diagnosis and treatment

发布机构：

美国静脉联盟

发布日期：

2022-03-08

简要介绍：

-2022年3月，美国静脉联盟(AVF)联合美国静脉和淋巴学会(AVLS)、血管内科学会(SVM)共同发布淋巴水肿的诊断和治疗专家共识。淋巴水肿带来了巨大经济和社会负担，本文主要针对淋巴水肿的诊断和治疗形成专家共识，内容涉及淋巴水肿的危险因素，诊断检查以及治疗和管理。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2022 AVF／AVLS／SVM专家共识：淋巴水肿的诊断和治疗.pdf)] GetToolGuiderByIdResponse(projectId=1, id=932aa1c0023e2100, title=2022 AVF/AVLS/SVM专家共识：淋巴水肿的诊断和治疗, enTitle=The American venous forum, American vein and lymphatic society and the society for vascular medicine expert opinion consensus on lymphedema diagnosis and treatment, guiderFrom=Phlebology, authorId=0, author=, summary=, cover=https://img.medsci.cn/202239/1646803188329_1608702.jpg, journalId=0, articlesId=null, associationId=1143, associationName=美国静脉联盟, associationIntro=null, copyright=0, guiderPublishedTime=Tue Mar 08 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p>-<span style="color: #373737;">2022年3月，美国静脉联盟(AVF)联合美国静脉和淋巴学会(AVLS)、血管内科学会(SVM)共同发布淋巴水肿的诊断和治疗专家共识。淋巴水肿带来了巨大经济和社会负担，本文主要针对淋巴水肿的诊断和治疗形成专家共识，内容涉及淋巴水肿的危险因素，诊断检查以及治疗和管理。</span></p>, tagList=[TagDto(tagId=10118, tagName=淋巴水肿)], categoryList=[CategoryDto(categoryId=92, categoryName=血管外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3911, appHits=133, showAppHits=0, pcHits=670, showPcHits=3778, likes=1, shares=17, comments=4, approvalStatus=1, publishedTime=Wed Mar 09 15:13:00 CST 2022, publishedTimeString=2022-03-08, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=dajiong, createdTime=Fri Mar 04 00:15:54 CST 2022, updatedBy=1608702, updatedName=dajiong, updatedTime=Sat Jan 06 22:42:21 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2022 AVF／AVLS／SVM专家共识：淋巴水肿的诊断和治疗.pdf)])
2022 AVF／AVLS／SVM专家共识：淋巴水肿的诊断和治疗.pdf
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1240393, encodeId=0495124039342, content=淋巴水肿, beContent=null, objectType=guider, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c7a5687904, createdName=ms8000001588433380, createdTime=Mon Aug 22 23:14:17 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227223, encodeId=4cdd122e22399, content=下载学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eouShoVRPZvFshog2V4Bs8JhDIybaiaNUp16CYicwfDeRB6KoOUPj3fibYhRSsWDJ2LGJM8fFQVIrdnQ/132, createdBy=f44f2325690, createdName=苏新攀, createdTime=Sat Jun 18 17:07:53 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203768, encodeId=53dc1203e688c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAZjM2PU3HVE0W3hIsh2eOKV4qzVLP3FRhDic3ymaptg1ibJdOR22AfRbzBGett4FWUwzfnzibTOibibg/132, createdBy=96b65238521, createdName=石头1492, createdTime=Fri Mar 18 12:45:53 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202305, encodeId=eb9e120230567, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aaaf6550393, createdName=ms9000001528745170, createdTime=Sun Mar 13 20:50:13 CST 2022, time=2022-03-13, status=1, ipAttribution=)]
    2022-08-22 ms8000001588433380

    淋巴水肿

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1240393, encodeId=0495124039342, content=淋巴水肿, beContent=null, objectType=guider, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c7a5687904, createdName=ms8000001588433380, createdTime=Mon Aug 22 23:14:17 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227223, encodeId=4cdd122e22399, content=下载学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eouShoVRPZvFshog2V4Bs8JhDIybaiaNUp16CYicwfDeRB6KoOUPj3fibYhRSsWDJ2LGJM8fFQVIrdnQ/132, createdBy=f44f2325690, createdName=苏新攀, createdTime=Sat Jun 18 17:07:53 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203768, encodeId=53dc1203e688c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAZjM2PU3HVE0W3hIsh2eOKV4qzVLP3FRhDic3ymaptg1ibJdOR22AfRbzBGett4FWUwzfnzibTOibibg/132, createdBy=96b65238521, createdName=石头1492, createdTime=Fri Mar 18 12:45:53 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202305, encodeId=eb9e120230567, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aaaf6550393, createdName=ms9000001528745170, createdTime=Sun Mar 13 20:50:13 CST 2022, time=2022-03-13, status=1, ipAttribution=)]
    2022-06-18 苏新攀

    下载学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1240393, encodeId=0495124039342, content=淋巴水肿, beContent=null, objectType=guider, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c7a5687904, createdName=ms8000001588433380, createdTime=Mon Aug 22 23:14:17 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227223, encodeId=4cdd122e22399, content=下载学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eouShoVRPZvFshog2V4Bs8JhDIybaiaNUp16CYicwfDeRB6KoOUPj3fibYhRSsWDJ2LGJM8fFQVIrdnQ/132, createdBy=f44f2325690, createdName=苏新攀, createdTime=Sat Jun 18 17:07:53 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203768, encodeId=53dc1203e688c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAZjM2PU3HVE0W3hIsh2eOKV4qzVLP3FRhDic3ymaptg1ibJdOR22AfRbzBGett4FWUwzfnzibTOibibg/132, createdBy=96b65238521, createdName=石头1492, createdTime=Fri Mar 18 12:45:53 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202305, encodeId=eb9e120230567, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aaaf6550393, createdName=ms9000001528745170, createdTime=Sun Mar 13 20:50:13 CST 2022, time=2022-03-13, status=1, ipAttribution=)]
    2022-03-18 石头1492

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1240393, encodeId=0495124039342, content=淋巴水肿, beContent=null, objectType=guider, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c7a5687904, createdName=ms8000001588433380, createdTime=Mon Aug 22 23:14:17 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227223, encodeId=4cdd122e22399, content=下载学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eouShoVRPZvFshog2V4Bs8JhDIybaiaNUp16CYicwfDeRB6KoOUPj3fibYhRSsWDJ2LGJM8fFQVIrdnQ/132, createdBy=f44f2325690, createdName=苏新攀, createdTime=Sat Jun 18 17:07:53 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203768, encodeId=53dc1203e688c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAZjM2PU3HVE0W3hIsh2eOKV4qzVLP3FRhDic3ymaptg1ibJdOR22AfRbzBGett4FWUwzfnzibTOibibg/132, createdBy=96b65238521, createdName=石头1492, createdTime=Fri Mar 18 12:45:53 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202305, encodeId=eb9e120230567, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aaaf6550393, createdName=ms9000001528745170, createdTime=Sun Mar 13 20:50:13 CST 2022, time=2022-03-13, status=1, ipAttribution=)]
    2022-03-13 ms9000001528745170

    学习了

    0

相关指南

2020 ISL共识文件：外周淋巴水肿的诊断和治疗

国际淋巴学协会International Society of Lymphology · 2020-03-01